Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation

In France, the Afssaps is the body in charge of the evaluation of pharmacodependance. In order to fulfil its mission, the Afssaps has created a network of 11 Centres for Evaluation and Information on Pharmacodependance (CEIP), coordinated by the Drugs and Psychotropics Unit. Pharmacodependence notifications issued by professionals are collected by each Centre which evaluates them. Nantes' CEIP created an original tool to harmonize case reporting and make it possible to homogeneously evaluate the seriousness of pharmacodependence cases as each CEIP had his own way of analysing his cases. The aim of this study is to assess this tool.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Drug Abuse Chemically-Induced Disorders Drug Dependence Mental Disorders Substance-Related Disorders

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Pellegrin, Bordeaux, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.

Treatment and study plan

Primary outcomes

Psychometrics properties Evaluation of the new questionnaire centered on addiction to medicine .

Time frame: At the beginning of the study

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Important dates

Study start: 2008
Primary completion: 2011
Study completion: 2013
First posted: Jan 20, 2010
Registry last updated: Sep 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed